POLICY BRIEFINGS


Hart Health Strategies provides a comprehensive policy briefing on a weekly basis. This in-depth health policy briefing is sent out at the beginning of each week. The health policy briefing recaps the previous week and previews the week ahead. It alerts clients to upcoming congressional hearings, newly introduced bills, regulatory announcements, and implementation activity related to the Patient Protection and Affordable Care Act (PPACA) and other health laws.


THIS WEEK'S BRIEFING - DECEMBER 31, 1969


WH Rescission Request Expected Early This Week


The White House plans to ask Congress for $11 billion in discretionary spending cuts from old funding accounts early this week. The rescission request is expected to impact years-old spending that has been approved but not yet spent and is not expected to affect money included in the $1.3 trillion omnibus spending package passed by Congress earlier this year. It is the first in a series of claw backs the White House plans to make over the course of this year. Congress has 45 days to consider the request before it expires. During that time, the funding outlined in the rescission package is frozen and unable to be spent by federal agencies. For more information on the rescission process, history, and potential impact on health programs, please refer to the Hart Health Strategies Inc. document titled “Rescission Explained: A Primer on the Impoundment Control Act,” attached to this week’s newsletter.


Trump to Deliver Drug Price Address Tuesday


President Trump’s speech on the price of prescription drugs will take place on Tuesday, May 8, according to latest reports. The President is expected to outline his plans to lower drug costs. The speech had originally been scheduled for April 26 but was postponed when Secretary of the U.S. Department of Health and Human Services (HHS) Alex Azar was hospitalized. According to Azar, the President’s plan extends beyond the proposals contained in his 2019 budget. The speech is expected to address high list prices, high out of pocket costs for Medicare beneficiaries, 340B program reform, and the issue of foreign nations benefiting from high drug prices in the United States.



December 31, 1969: | Page 1 Page 2 Page 3 Page 4

SERVICES




BRIEFING ARCHIVE


 -  2018